fashion -WSS

fashion

author：entertainment 2025-09-30 21:58:07 - browse：38

Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation. — Suzanne Kreiter/Globe staff

WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Why Eli Lilly’s earnings didn’t quite live up to the hype

WSS

Sanofi strikes deal with Novavax, boosting the vaccine maker

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

Ebola vaccine can save some who are already sick, per new study

H5N1 communication has been strictly for the birds

Doctors on social media are being harassed and cyberbullied

Medicare says breakthrough device reimbursement rule to come by summer

knowledge

fashion

entertainment

After affirmative action ruling, medical educators look to 'holistic review'

Steward Health Care files for bankruptcy

Medicare details structure of new drug price negotiation program

How to improve immunocompromised access to mAb treatments

In Memoriam: Notable people who died in 2023

ACIP vaccine advisory panel sees its vacancies filled

As demand for Covid shots wanes, Moderna seeks its next success

Why Eli Lilly’s earnings didn’t quite live up to the hype

Wildfire smoke exposes gaps in outdoor worker protections

Eli Lilly reports tirzepatide MASH success during Q4 earnings

focus

Brain worms: The science behind RFK Jr.'s parasitic infection

Why Eli Lilly’s earnings didn’t quite live up to the hype

Study: AI not yet building 'n

Tome Biosciences co

Study: Adult vaccinations pay for themselves in societal benefits

Study: AI not yet building 'n

focus

Wikipedia

explore

focus